Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 16/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CFTR | P13569 | 3/20 | 0.46 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7594455 | 1.00 | TACR1 (0.50) | TACR1CYP2D6CFTRHCRTR2 | |
| SCHEMBL7867202 | 0.89 | TACR1 (0.60) | TACR1CYP2D6CFTR | |
| SCHEMBL7591379 | 0.89 | TACR1 (0.49) | TACR1CYP2D6CFTRHCRTR2 | |
| SCHEMBL7133654 | 0.89 | TACR1 (0.60) | TACR1CYP2D6CFTR | |
| SCHEMBL7137909 | 0.89 | TACR1 (0.51) | TACR1CYP2D6CFTR | |
| SCHEMBL8708427 | 0.89 | TACR1 (0.51) | TACR1CYP2D6CFTR | |
| SCHEMBL7135463 | 0.89 | TACR1 (0.51) | TACR1CYP2D6CFTR | |
| SCHEMBL7583806 | 0.88 | TACR1 (0.48) | TACR1CYP2D6CFTRHCRTR2 | |
| SCHEMBL7590814 | 0.87 | TACR1 (0.47) | TACR1CYP2D6CFTRHCRTR2 | |
| SCHEMBL6604763 | 0.87 | TACR1 (0.65) | TACR1HCRTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0780375-B1 | 3-((5-substituted benzyl)amino)-2-phenylpiperidines as substance p antagonists | PFIZER (US) | 2002-09-11 | — | — | EP | disclosed |
| US-5789423-A | ANTIALLERGENS, ANTIINFLAMMATORY AGENTS; GASTROINTESTINAL AND CENTRAL NERVOUS SYSTEM DISORDERS | PFIZER INC. (US) | 1998-08-04 | — | — | US | disclosed |
| EP-0780375-A1 | 3-((5-substituted benzyl)amino)-2-phenylpiperidines as substance p antagonists | PFIZER INC. (US) | 1997-06-25 | — | — | EP | disclosed |